Advertisement

Topics

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

04:48 EST 26 Nov 2014 | BioPortfolio

This article has expired, however you can still download the PDF.
Preview:
Summary Adimmune Corporation (Adimmune) is a pharmaceutical company. The company manufactures products, such as vaccines, diagnostics, and biological products. The company’s vaccine products include Japan encephalitis vaccine, tetanus toxoid adsorbed va....

Other Sources for this Article

Original Article: Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

NEXT ARTICLE

More From BioPortfolio on "Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...